3 February 2020 - The Global Transfection Reagent & Equipment Market size is estimated to reach USD 1.08 billion by 2022, exhibiting a 7.4% CAGR during the forecast period. The primary factor for the growth of this segment is the rising demand for the production of the recombinant protein.
Advancements in the clinical development of biopharmaceuticals, is anticipated to boost the demand for gene analysis and gene expression studies for the purpose of bio-authenticity and investigative analysis. The aforementioned factor is attributive to drive the segment revenue potentially in the coming years.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/transfection-reagents-equipment-market
Patent cliff generated in recent years is pronouncing the need for production of several moieties which depends on the laboratory analysis thus inducing industrial growth in this market. Anticipated rise in the analytical methods is expected to increase the adoption of such technologies in the coming years.
Additionally, with established healthcare infrastructure and reimbursement policy, many pharma companies are expanding their business in western geographic segments which would induce innovation and growth in the biotechnology industry over the forecasted period.
Method Insights
Electroporation method for conducting transfection process holds the largest share of the revenue. The larger share is attributive to its diverse versatility in application, user-friendliness, and consequent higher implementation of this technique. However, the misuse of this method has caused cell damage which is expected to slow down its adoption.
Liposomal method is second only to the electroporation method of transfection. The other segments for the implementation of method includes adenoviral vectors and particle bombardment which are expected to provide positive growth in the forecasted period.
Bombardment equipment and particle acceleration have witnessed a reduction in the cost over the past years which will boost its market penetration. This method is expected to grow at the fastest rate owing to increasing investment in order to bring about technological innovations in this market.
Application Insights
Gene expression accounted for the largest share of revenue in 2016 as a result of larger use of the technology in this segment. Vaccine biopharmaceuticals production requires substantial usage of gene expression methods based on the principles of transfection.
Proteomic analyzers and cytology-based programs (for research purpose) are expected to witness demand in biomedical and oncology studies. This factor is expected to fuel progress in the coming years.
View Full Report with TOC @ https://www.millioninsights.com/industry-reports/transfection-reagents-equipment-market/request-sample
Regional Insights
North American region witnessed highest penetration in 2016 owing to the presence of large number of research and biopharmaceutical production institutes, biosimilar drugs, vaccines, and clinical organizations for R&D.
With the rise in number of academic institutes engaged in basic research for protein and genetic research which are highly supported by the government, the market revenue for transfection is anticipated to witness potential increment. Also, a large number of cancer research and specialized biomedical institute provides a platform for the development of this technology.
Europe with respect to market share is close to North America and has gained significantly high revenue as per the estimation. With favorable government policy, large-scale gene expression analysis is widely implemented in this region. Also, large-scale development in reverse transfection has provided a strong base for penetration of the products in this region.
Asia-Pacific region is expected to witness fastest growth over the forecast period owing to progress in healthcare infrastructure, for example, setting up of bio-incubators for research purpose, rise in government funding for basic research held in academic institutions, increasing adoption of proteomics and cytological expression.
Competitive Insights
Roche, Promega and Life Technologies (a subsidiary of Thermo Fisher) are renowned players operating in this market. These players are engaged in implementing strategic initiatives such as product development, diversification, vertical and horizontal integration, and in some cases divestiture.
Other companies that are operating in this market are Lonza, Qiagen, Mirus Bio LLC, OriGene Technologies, EMD Millipore, VWR International, BTX and SignaGen Laboratory.
Market Segment:
Transfection Reagent & Equipment Product Outlook (Revenue, USD Million, 2014 - 2022)
- Reagents
- Equipment
Transfection Reagent & Equipment Method Outlook (Revenue, USD Million, 2014 - 2022)
- Electroporation
- Liposomes
- Particle Bombardment
- Microinjection
- Adenoviral Vectors
- Direct Microinjection
- Calcium phosphate
- DEAE - dextran
- Magnetic Beads
- Activated Dendrimers
- Laserfection
Transfection Reagent & Equipment Application Outlook (Revenue, USD Million, 2014 - 2022)
- Gene Expression Studies
- Protein Production
- Transgenic Models
- Therapeutic Delivery
- Cancer Research
- Biomedical Research
Transfection Reagent & Equipment Regional Outlook (Revenue, USD Million, 2014 - 2022)
- North America
- U.S.
- Canada
- Europe
- Germany
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: [email protected]
Visit Our Blog: www.millioninsights.blogspot.com
When generating this Transfection Reagents and Equipment market report, myriad of objectives of the marketing research have been kept in mind.
All the data and statistics included in this report is derived from the reliable sources only e.g.
journals or white papers of companies etc.
This market research report contains several parameters which are thoroughly studied by the experts.
This market research report provides with a thorough analysis of market and numerous related factors that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis.Transfection reagents and equipment market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market to growing with the CAGR of 7.0 % in the above-mentioned forecast period.With the market statistics covered in the Transfection Reagents and Equipment report, it has become achievable to gain Europe perspective for the international business.
Transfection Reagents and Equipment Market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025.
The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report at : https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-transfection-reagents-and-equipment-marketCompetitive Analysis: Asia-Pacific Transfection Reagents and Equipment MarketSome of the prominent participants operating in this Asia-Pacific Transfection Reagents and Equipment Market are Thermo Fisher Scientific Inc. is expected to dominate the global transfection reagents and equipment market Sigma-Aldrich, Inc (distributor of F. Hoffman La.
Roche) followed by Promega Corporation., QIAGEN.. Key Pointers Covered in the Asia-Pacific Transfection Reagents and Equipment Market Trends and Forecast to 2026Asia-Pacific Transfection Reagents and Equipment Market New Sales VolumesAsia-Pacific Transfection Reagents and Equipment Market Replacement Sales VolumesAsia-Pacific Transfection Reagents and Equipment Market Installed BaseAsia-Pacific Transfection Reagents and Equipment Market By BrandsAsia-Pacific Transfection Reagents and Equipment Market SizeAsia-Pacific Transfection Reagents and Equipment Market Procedure VolumesAsia-Pacific Transfection Reagents and Equipment Market Product Price AnalysisAsia-Pacific Transfection Reagents and Equipment Market Healthcare OutcomesAsia-Pacific Transfection Reagents and Equipment Market Cost of Care AnalysisAsia-Pacific Transfection Reagents and Equipment Market Regulatory Framework and ChangesAsia-Pacific Transfection Reagents and Equipment Market Prices and Reimbursement AnalysisAsia-Pacific Transfection Reagents and Equipment Market Shares in Different RegionsRecent Developments for Asia-Pacific Transfection Reagents and Equipment Market CompetitorsAsia-Pacific Transfection Reagents and Equipment Market Upcoming ApplicationsAsia-Pacific Transfection Reagents and Equipment Market Innovators StudyGet Detailed TOC:https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-transfection-reagents-and-equipment-marketScope of the Transfection Reagents and Equipment MarketAsia-Pacific Transfection Reagents and Equipment Market, By Product (Reagents, Equipment), By Method (Physical Method, Biochemical Methods, Viral Methods), By Application (Protein Production, Biomedical Research, Therapeutic Delivery), By End User (Academics & Research Institutes, Pharmaceutical & Biotechnology Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC) – Industry Trends and Forecast to 2025Asia-Pacific Transfection Reagents And Equipment Market is estimated to grow with the highest CAGR in the forecast period 2018 to 2025.
The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.Market Segmentation: Asia-Pacific Transfection Reagents and Equipment MarketThe Asia-Pacific transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method.
In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR.
